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Abstract  – In this report we examine the effectiveness
of WISER in identification of a chemical culprit during a
chemical  based  Mass Casualty  Incident  (MCI).  We also
evaluate and compare Binary Decision Tree (BDT) and
Artificial  Neural  Networks  (ANN)  using  the  same
experimental  conditions  as  WISER.  The  reverse
engineered  set  of  Signs/Symptoms  from  the  WISER
application  was  used  as  the  training  set  and  31,100
simulated  patient  records  were  used  as  the  testing  set.
Three sets of simulated patient records were generated by
5%, 10% and 15% perturbation of the Signs/Symptoms of
each chemical record. While all three methods achieved a
100%  training  accuracy,  WISER,  BDT  and  ANN
produced performances in the range of: 1.8%-0%, 65%-
26%, 67%-21% respectively. A preliminary investigation of
dimensional  reduction  using  ANN  illustrated  a
dimensional  collapse  from 79 variables  to  40 with little
loss of classification performance.  
Keywords:  WISER,  MCI,  NLM,  TOXNET,  HSDB,
Machine Learning.
 1 Introduction
Improvement of the healthcare system in the United States
is  the  subject  of  great  interest  and  debate  in  the  social,
political, and economical arenas of our society. One obvious
approach in improving the overall healthcare system is by
eliminating  the  existing  inefficiencies  that  impede  our
system1–3. Removal of inefficiencies impacts our system of
healthcare in two inherent ways: significant improvement of
the  patient  outcome,  and  a  reduction  in  the  cost  of
healthcare. Although in principle it is clear that removal of
inefficiencies is beneficial, in practice there has been little
effort in removal of the existing inefficiencies. This lack of
effort is rooted in the complexity of our healthcare system
that  has  manifested  itself  as  a  lack  of  consensus  on  the
method of removing the existing inefficiencies. 
Integration of technological advances in our healthcare such
as utilization of mobile devices,  availability of broadband
systems  with  high  throughput,  and  embedded  clinical
decision systems4–6 can be cited as some approaches that can
reduce overall inefficiencies of our healthcare system. One
branch  of  healthcare  that  can  benefit  from  better
streamlining of patient-care through integration of clinical
decision  support  is  in  emergency  care  during  a  mass
casualty incident7 (MCI). The rapid operational tempo of an
Emergency Room (ER) serves as an ideal vehicle to study
any  existing  inefficiencies  while  the  resource-limited
conditions of an MCI will help in clearly gauging the impact
of any proposed improvements. MCI events clearly require
rapid treatment of patients with minimum interruption for
data collection, while optimal treatment of patients requires
the  hindering  and  cumbersome  completion  of  detailed
patient  information  to  identify  the  culprit  chemical
substance.  These  two  competing  objectives  have
traditionally  been  a  major  impediment  in  optimizing  the
MCI treatment process with a natural priority extended to
rapid treatment of patients. Therefore, there has been little
advances in improving treatment of chemical MCI events.
Research is needed to build a better understanding of the
information and technological needs of the healthcare and
public  health  workforce  during  emergency  decision
making8.
A limited set of clinical decision support software have been
introduced by the larger community9.  The National Library
of Medicine has  created the Wireless  Information System
for  Emergency  Responders10 (WISER),  which  allows
emergency responders to identify a list of possible chemical
substances based on the observed patient symptoms. The US
Department of Health and Human Services has developed
another  software  tool  named  the  Chemical  Hazards
Emergency  Medical  Management-Intelligent  Syndromes
Tool11 (CHEMM-IST).  CHEMM-IST  is  a  prototype  that
guides first-responders through a series of questions related
to signs and symptoms that leads to a probabilistic diagnosis
of  four syndromes rather  than a list  of  chemical  hazards.
Although such software make significant strides in assisting
the process of emergency care, their efficacy have not been
assessed during a chemical based MCI. 
In this report we examine the effectiveness of WISER as the
potential  software  for  early  identification  of  chemical
material  during  an  MCI  event  using  simulated  patient
signs/symptoms (SSx) that we have reverse engineered from
WISER. We also report results from Binary Decision Tree
and Artificial Neural Network applications to the same set
of simulated patient data. We conclude by reporting results
of our initial investigation aimed at dimensional reduction
of  SSx  space.  Our  final  objective  is  to  challenge  the
paradigm that rapid patient treatment is in contrary to data
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gathering that  will  assist  in  early identification of  culprit
chemical.  We contest  that  careful  design  of  sophisticated
clinical  decision support  tools  can satisfy both competing
objectives  of  rapid  information  gathering  and  accurate
chemical identification processes.
 2 Materials and Methods
Our  general  approach  consists  of  creating  signs  and
symptoms  (SSx)  for  simulated  patients  using  a  reverse-
engineered table of SSx from the WISER application. Using
the  simulated  data,  we  then  proceed  to  evaluate  the
successful identification of a culprit chemical using WISER,
Binary Decision Tree (BDT), and Artificial Neural Network
(ANN) machine learning approaches. 
 2.1 WISER
Wireless  Information  System  for  Emergency
Responders10 (WISER)  is  a  free  application  available  for
Android  and  iOS,  which  can  also  be  downloaded  as  a
standalone  application on a  desktop computer.  Developed
by the National Library of Medicine (NLM), WISER is a
system  designed  to  assist  emergency  responders  in
hazardous  material  incidents.  It  provides  a  wide  range of
information  on hazardous  substances,  including substance
identification support, physical characteristics, human health
information  and  containment  and  suppression  advice.  Its
key  features  include  rapid  access  to  the  most  important
information about a hazardous substance by an intelligent
synopsis engine and display called “Key Info”, and access
to NLM’s Hazardous Substances Data Bank (HSDB), which
contains  detailed  peer-reviewed information on  hazardous
substances and comprehensive decision support. 
The key feature in WISER most relevant to this work is the
Substance  ID Support  (SIDS).  This  allows an  emergency
responder to input patient SSx, from which the SIDS will
identify  one  or  more  likely hazardous  chemicals  causing
those  symptoms.  WISER contains  a  checklist  of  79  SSx,
which are input for selected systems of the body through an
interactive  tool  as  seen  in  Figure  1A. As  the  signs  and
symptoms are entered (Figure 1B) the pre-populated library
of 438 hazardous substances is  successively reduced. The
user  can  view  the  list,  select  a  substance  and  view
toxicology  information  available  in  the  HSDB,  which
contains  data  from  the  NLM  Toxicology  Data
Network12 (TOXNET).  The  HSDB  data  file  contains
information  on  human  exposure,  industrial  hygiene,
emergency  handling  procedures,  environmental  fate,
regulatory requirements and related area.
(a) (b)
Figure 1. Wireless Information System for Emergency Responders
(WISER) for Android operating system. Panel (a) is the Interactive
tool and panel (b) is the symptom selection interface. Panel (b) also
shows the substance ID support in which an emergency responder
can identify an unknown substance based on signs and symptoms
of victims.
 2.2 Reverse engineering and compression of 
WISER database
A  thorough  evaluation  of  WISER  necessitated  reverse
engineering of all WISER’s substances with their associated
SSx.  This  task  was  performed  by  manually  reviewing
NLM’s HSDB and parsing the SSx for each substance. An
example of the resultant table of SSx is shown in Figure 2.
Each of the 438 substances found in WISER is represented
in  the  first  column  in  this  table,  and  the  following  79
columns represent the corresponding SSx found in WISER
for a given chemical. The presence or absence of each SSx
is indicated by a 1 or a 0 respectively. 
Figure 2.WISER’s reconstructed database using NLM’s toxicology
information stored in the Hazardous Substances Data Bank 
(HSDB).
Examination  of  the  created  database  revealed  several
substances with identical SSx profiles. In such instances, a
cluster of chemicals was reduced to a single representative.
The  list  of  uniquely  distinguishable  chemicals  was  then
reduced  from  438  substances  to  311  unique  substances,
which  serves  as  the  reverse-engineered  list  of  unique
chemicals.
 2.3 Creation of Simulated Victims (Test Set)
Simulated  patient-data  were  generated  from  the  ideal
database  of  311  unique  substances  by  perturbation  of
randomly selected Ssx.  This was done to precisely control
the amount of missing data.  Signs and symptoms related to
a real MCI would be ideal, however accurate patient records
during  these  scenarios  are  limited  and  usually
incomplete13,14.  Each substance was replicated 100 times to
create a  reasonably extensive testing set  that  consisted of
31,100 simulated victims. Three data-sets were created by
random toggling  of  selected  SSx  at  5%,  10%,  and  15%
selection  rates.  To  ensure  the  proper  random  selections,
probability density profiles were examined for the number
of perturbed SSx across each of the simulated patient-data.
An overview of the perturbed data-sets (shown in Figure 3)
corroborates the intended rates of perturbation. 
Figure 3.The Kernel Density Estimation of the 3 test data-sets. Test
data were created by starting with the ideal table of symptoms 
from WISER and changing the symptoms by 5%, 10%, and 15%.
 2.4 Overview of Machine Learning 
Approach
Our general  work-flow for creating predictive models can
be  found  in  Figure  4.  Supervised  machine  learning
techniques were utilized in the Matlab 2015Rb environment
to identify patterns and to develop predictive models. Our
process began by importing the reverse-engineered database
of 311 unique substances followed by training of two types
of classification models: Binary Decision Trees (BDT) and
Artificial Neural Networks (ANN). After successful training
of  a  given  model,  the  known SSx  profile  for  all  311
substances  was  tested  on  the  trained  model  to  establish
proper  learning  (testing  for  memorization  versus
generalization is conducted in a different step). The model
with the highest accuracy during the training was chosen as
the final model. Evaluation of each trained model was then
assessed  using  the  SSx  profiles  of  the  31,100  simulated
victims. A prediction accuracy was calculated as shown in
Equation 2. In this equation A represents the accuracy of the
model  (expressed  in  %),  Nc indicates  the  number  of
correctly identified chemicals, and Ntotal represents the total
number  of  trials  (31,100  in  this  case).  The  next  sections
provide  a  more  detailed  description  of  the  training  and
testing for each model.
A=(N c /N Total)⋅100   (1)
Figure 4.Work-flow for exploration of data, training models and 
predicting substances using supervised machine learning 
techniques
 2.5 Training and Testing of Classification 
Methods
We evaluated three common classification approaches in our
investigation.  The  classification  approaches  consisted  of:
database  look-up  (as  implemented  by  WISER),  Binary
Decision Trees, and Artificial Neural Networks. Details for
each of the three approaches are described in the following
sections.
 2.5.1 Database look-up (WISER)
The interactive nature of WISER was the limiting factor in
automated  and  batch  evaluation  of  WISER  for  31,100
patients each represented by 79 SSx. This limitation served
as one of  our primary motivations in  establishing a local
database  of  WISER  SSx.  The  first  step  in  replicating  a
process  identical  to  the  WISER  application  was  to
understand  its  selection  logic.  WISER  selects  chemicals
only based on the presence of a SSx and not its absence.
Therefore, WISER will identify the entire library of 438 (or
311  unique)  chemicals  as  the  potential  list  of  possible
exposed chemicals for a patient exhibiting no apparent SSx.
While this logic may appear questionable in our application,
we proceeded with our evaluation of WISER in an exact
fashion.  Our  initial  evaluation  of  WISER  consisted  of  a
query-based search of our local database of chemicals using
MySQL database engine housed on an Ubuntu LTS 14.04
server. This approach required a database look-up for SSx of
all  31,100 simulated patients.  Since the WISER approach
may  (and  most  likely  will)  return  a  list  of  potential
chemicals, the database look-up step is followed by a search
for existence of  the right  chemical  in  the list  of  returned
chemicals. Although the time requirement of this evaluation
mechanism was feasible (in the order of a week) for a list of
31,100  patients,  it  is  an  impractical  approach  for  future
investigations with larger  data-sets in order  to  establish a
more thorough evaluation of the methods. Our most current
approach  consists  of  an  in-house  developed  program  to
simulate this table look-up process. Our evolved approach
returns the identical results that WISER would return while
reducing  the  search  time  from  months  to  seconds.  Our
testing process consisted of recording the number of times
that the correct chemical was present in the list of returned
chemicals similar to Equation 1. 
Since  WISER  operates  in  a  deterministic  fashion,  a
statistical model of its performance can be developed. By
assuming  that  every  patient  will  undergo  alteration  of
exactly  n SSx,  it  can  be  argued  that  WISER's  outcome
should closely follow a success rate shown in Equation  2.
This equation lists  all  of the possible perturbation of SSx
that  will  result  in  removal  of  the  correct  chemical  in
WISER’s  resultant  list.  This  equation  can  be  simplified
using the Binomial theorem as shown in Equation 2. Based
on binomial distribution modeling of the WISER's outcome,
a success rate of 6.25%, 0.4% and 0.02% can be expected
for the cases of 5%, 10% and 15% perturbation of SSx.
r=1−∑
i=1
n
(ni )pi(1−p)(n−i )= 12n   (2)
 2.5.2 Binary Decision Tree
A  Binary  Decision  Tree  (BDT)  was  trained  using  the
reverse-engineered  WISER  database  within  the  Matlab
2015Rb environment. A maximum deviance reduction was
used as the split criterion with 350 maximum splits. Each of
the 311 chemicals was replicated 312 times to facilitate the
construction  of  a  complete  tree  and  in  consideration  of
Matlab's training algorithm. Under this training conditions,
a classification rate of 100% was achieved. 
Our  adopted  testing procedure consisted of  observing the
chemical identification accuracy of the trained network with
the simulated patient-data. It is noteworthy that the trained
BDT was based on ideal data while the testing was based on
the perturbed data-sets (5%, 10% and 15% perturbation). 
 2.5.3 Artificial Neural Network
An Artificial  Neural  Network (ANN) was trained through
the Pattern Recognition toolbox of the Matlab 2015Rb using
back-propagation learning algorithm15–17. The unique set of
311 ideal chemical SSx were used during the training of the
ANNs. The training set consisted of 5 identical replicas for
each  of  the  unique  311  chemicals  (for  a  total  of  1555
training  patterns)  in  order  to  accommodate  a  random
selection of the cross-validation and testing sets. The 1555
training  patterns  were  randomly partitioned  into  70% for
training,  15%  for  cross-validation  and  15%  for  testing.
Numerous ANNs were trained and tested for selection of the
optimal  number  of  hidden  neurons.  Our  investigation
concluded  20  neurons  as  the  optimal  number  of  hidden
neurons.  The  final  trained  ANN  model  exhibited  cross-
entropy results of: 4.4 for the training set, 12.7 for the cross-
validation set, and 12.7 for the testing set. These outcomes
correspond to: 0% error for the training set, 2.1% error for
the validation set and 2.1% for the testing set. 
To test the performance of the network with unknown data,
the 31,100 simulated patient-data were used as inputs for the
ANN trained with ideal chemical data. 
 3  Results and Discussion
 3.1 Database look-up (WISER)
The results of WISER database look-up approach are shown
in Table 1 and exhibit a reasonable correlation to the binary
distribution model shown in Equation 2. The rapid decay in
performance  of  WISER  is  easily  expected.  We  use  the
results of WISER as the basis of comparison since it is the
most prominent and existing mechanism. 
Table 1: Prediction accuracy results from WISER testing using 
31,100 simulated patient-data perturbed at 5%, 10% and 15%.
Data-set Prediction
Accuracy
Max Min
5% Perturbed 1.8% 7% 0%
10% Perturbed 2.3x10-2% 1% 0%
15% Perturbed 0.0% 0% 0%
Figure 5: The Kernel Density Estimations from testing WISER 
with 31,100 simulated patient-data perturbed at 5%, 10% and 15%
 3.2 Binary Decision Tree
Testing results for BDT are shown in Table 2. In this table
the first columns represent the severity of the perturbation
and  the  second  column  corresponds  to  the  classification
accuracy of the BDT. The third and fourth columns of Table
2 list the minimum and maximum performance across all of
the  311  chemical  substances.  To  better  understand  the
performance of the BDT across the entire ensemble of 311
chemicals, a probability density function was created using
the Kernel Density Estimation (KDE) technique15,18. Figure
6 illustrates  the  statistics  for  BDT classification  behavior
over the entire 100 representatives of each 311 chemicals.
The  nearly Gaussian  distribution  of  the  statics  indicate  a
very well behaved system without any particular bias. 
Another important factor to monitor during the construction
of  a  BDT  is  the  topology  of  the  final  tree.  Figure  7
illustrates the topology of the final tree (in the interest of
simplicity the  labels  are omitted),  which indicates  a  very
well  balanced  tree  of  depth  9.  This  depth  is  in  perfect
theoretical agreement with the complexity of the problem,
serving  as  another  indication  of  a  successful  training
session. 
Table 2: Prediction accuracy results for Binary Decision Tree 
(BDT) testing using 31,100 simulated patient-data perturbed at 
5%, 10% and 15%.
Data-set Prediction
Accuracy
Max Min
5% Perturbed 64.9% 81% 53%
10% Perturbed 41.8% 54% 27%
15% Perturbed 25.6% 40% 13%
Figure 6.The Kernel Density Estimations from testing the Binary 
Decision Tree (BDT) model with 31,100 simulated patient-data 
perturbed at 5%, 10% and 15%.
Figure 7.Static binary decision tree for 311 unique chemicals found
in the National Library of Medicine’s Hazardous Substances Data 
Bank (HSDB).
 3.3 Artificial Neural Networks
The evaluation results of the ANN are shown in Table  3.
Similar to the results of BDT, the first two columns of this
table  indicate  the  severity  of  perturbation  and  outcome
accuracy, while columns three and four indicate the range of
the  outcomes  across  all  311  chemicals.  Remarkably  the
accuracy of BDT and ANN appear to be similar, while the
range of ANN's performance exhibit a larger variation. To
better understand the statistics of ANN's results, probability
density  profiles  were  created  for  each  of  the  experiment
using KDE using the exact parameters as the BDT (identical
kernels).  Similar  to  BDT,  the  Gaussian  nature  of  the
outcomes  indicate  a  well  behaved  and  unbiased  system.
Visual inspection of Figure 8 confirms the noted differences
in variation of outcomes compared to the BDT results. 
Table 3: Prediction accuracy results for the Artificial Neural 
Network (ANN) testing using 31,100 simulated patient-data 
perturbed at 5%, 10% and 15%.
Data-set Prediction
Accuracy
Max Min
5% Perturbed 67.2% 96% 28%
10% Perturbed 38.4% 73% 10%
15% Perturbed 21.4% 49% 3%
Figure 8.The Kernel Density Estimations from testing the Artificial
Neural Network (ANN) model with 31,100 simulated patient-data 
perturbed at 5%, 10% and 15%.
 3.4 Dimensional reduction
To  optimize  the  Artificial  Neural  Network  model,  we
examined the number of hidden neurons being used during
the  training  phase  of  the  model  development.  10  models
were  trained,  each  with  a  different  number  of  hidden
neurons starting with 10 hidden neurons, then incrementing
by 10 and the final model using 100 hidden neurons. After
the  model  was  created,  additional  testing  was  performed
using the  5% perturbed  data-set  and  the  amount  of  error
from the ANN was recorded. As seen in Figure 9, the results
show that as we increase the number of hidden neurons, the
amount of error from the ANN is reduced with the minimal
amount  of  error  being 15.4% at  100 hidden  neurons.  We
then examined training the ANN with only the first 40 SSx
instead  of  the  complete  database  of  79  SSx.  Again  10
models  were  trained  starting  with  10  hidden  neurons  at
increments of 10 to 100 hidden neurons. After training the
ANN, additional testing was also performed using the 5%
perturbed data-set and recording the ANN error. It  can be
seen in Figure  9, the results followed the same pattern as
with 79 SSx with the minimal amount of error being 25.8%
at 40 hidden neurons. This indicates that using the first 40
SSx  can  reduce  the  amount  of  collected  data  with  an
acceptable  reduction  in  the  classification  rate.  This  small
reduction  in  classification  can  potentially  be  minimized
through a more informed selection of SSx and analysis of
the MCI over the entire cohort of victims.  
Figure 9: Optimizing the number of hidden neurons used in 
training the Artificial Neural Network. We used the 5% perturbed 
simulated patient-data for additional testing on the model.
 4 Conclusion
Our  overall  approach  consisted  of  evaluating  WISER  in
application to MCI under more realistic conditions. We have
used the results of  WISER as the basis of comparison to
highlight  the  advantages  and  disadvantages  of  BDT  and
ANN,  two  common classification  approaches  in  machine
learning.  The  summary  of  results  shown  in  Figure  10
illustrates  the significant  improved chemical  identification
performance  that  can  be  obtained  from  BDT  or  ANN
compared to WISER. Results reported in section  3.1 (also
summarized in Figure 10) reflect the intolerance of WISER
to  erroneous and  imperfect  data;  a  condition  that  is  very
likely to occur during the chaos and confusion that occurs
during an MCI. Furthermore, WISER operates with a luxury
of reporting a potentially long list  of  unrelated chemicals
that share a common list of present SSx. Presenting a long
list of unrelated chemicals may provide additional confusion
during  an  MCI.  However,  creating  a  list  of  chemicals
affords the benefit of operating with fewer SSx. Therefore,
WISER exhibits the advantage of using as many or as little
number of SSx as are available while BDT and ANN require
a fixed number of SSx in their successful deployment. 
Results for BDT and ANN evaluations reported in sections
3.2 and  3.3 highlight  the  significant  robustness  of  these
more  sophisticated  approaches  compared  to  WISER.  In
summary, BDT and ANN show promise when compared to
WISER  for  quickly  and  accurately  identifying  a  culprit
chemical during a chemical MCI.  This gain in robustness is
achieved  through  the  use  of  these  machine-learning
techniques' ability to generalize and not simply memorize.
Furthermore, BDT provides the clear advantage of arriving
at a single chemical with requiring only 9 SSx (based on the
depth of the tree shown in Figure  7).  ANN exhibited the
same degree of robustness compared to the BDT but with
the apparent disadvantage of requiring all 79 SSx during the
process  of  substance  identification.  However  our
exploration of dimensional reduction and results shown in
section 3.4 support the possibility of using only 40 of the 79
SSx with little reduction in performance.
Our future investigations will focus on further reduction of
data  dimensionality  by  the  use  of  previously  established
methods such and Principal Component Analysis (PCA) or
Linear Discriminant Analysis15 (LDA).  AI tools employed
during  chemical  MCIs  could  dramatically  reduce  the
amount of information collected from patients resulting in
increased accuracy, precision, and efficiency in identifying
the chemical.
Figure 10.Overall prediction accuracy for each model tested with 
31,100 simulated patient-data perturbed at 5%, 10% and 15%
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